The pill, which contains an ingredient that helps deliver the fragile peptide to the body, is an alterative to an injectable version of the weight-loss drug, Wegovy, already on the market
The receptor for GLP-1 is the GLP-1 receptor (GLP1R gene, below in the genotype report section), a G-protein-coupled receptor
These changes might indicate the need for dose adjustments or could signal interactions with newly started medications or supplements
Table of Contents Why GLP-1 Medicines Cause Headaches Glucagon-like peptide-1 (GLP-1) receptor agonists including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda) are increasingly prescribed for type 2 diabetes management and weight loss
Working with a registered dietitian familiar with these medications can provide personalized guidance that balances symptom management with nutritional adequacyparticularly important for patients on these medications long-term for obesity management